AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22608494
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (vitamin E 800 mg, C 500 mg, zinc 40 mg) for 6 months
Trial: 22608494
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (pegylated interferon combined with ribavirin)
Trial: 17150287
Drug: 23-valent Pneumococcal
RxNorm normalized name: Streptococcus pneumoniae type 1 capsular polysaccharide antigen
DrugBank: Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent Pneumococcal Polysaccharide Vaccine (23vPPV) during the third trimester or at delivery
Trial: 15149751
Drug: Permixon 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permixon 320 mg/day
Trial: 11255445
Drug: Rivastigmine treatment
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine treatment (2 to 12 mg/d) for 26 weeks after 26 weeks of placebo treatment
Trial: 3555386
Drug: Adjunctive imipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive imipramine hydrochloride treatment
Trial: 1790567
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (1 mg/kg)
Trial: 405029
Drug: Meptazinol administered
RxNorm normalized name: meptazinol
DrugBank: Meptazinol (DB13478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol administered rectally
Trial: 19279518
Drug: Rosuvastatin (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (2.5 mg/day)
Trial: 20529243
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/day)
Trial: 30696326
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (12 weeks of supervised training twice weekly including interval-based aerobic exercise and resistance training)
Trial: 25530107
Drug: Low dialysate
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dialysate sodium concentration (5 mEq/L below serum sodium)
Trial: 25530107
Drug: High dialysate
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dialysate sodium concentration (5 mEq/L above serum sodium)
Trial: 18492531
Drug: MAS063DP cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAS063DP cream (n = 72)
Trial: 18492531
Drug: Vehicle cream
RxNorm normalized name: vehicle cream base no.160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle cream (n = 70)
Trial: 16812973
Drug: Etanercept (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (1 mg/kg)
Trial: 16812973
Drug: Etanercept (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (2 x 25 mg)
Trial: 16812973
Drug: Biological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological treatment
Trial: 7779574
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zinc gluconate twice (the evening before and 30 min before the test)
Trial: 1970070
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition supplement (250 ml, 20 g protein, 254 kcal) for a mean of 32 days
Trial: 31869755
Drug: LTG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG group during inactive pill with levonorgestrel
Trial: 31869755
Drug: LTG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG group during inactive pill with drospirenon
Trial: 31869755
Drug: LTG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG group during inactive pill with gestoden
Trial: 31708182
Drug: RTS,S/AS01 malaria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 malaria vaccine (4 doses)
Trial: 31708182
Drug: RTS,S/AS01 malaria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 malaria vaccine (3 doses) plus 1 comparator vaccine dose
Trial: 31708182
Drug: Comparator vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator vaccine doses (4 doses)
Trial: 29643323
Drug: voglibose (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: voglibose (0.2 mg/meal thrice daily)
Trial: 22616316
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg of morphine (group M1)
Trial: 22616316
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg of morphine (group M2)
Trial: 20045479
Drug: Pegfilgrastim (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegfilgrastim (single 6 mg dose)
Trial: 18022544
Drug: Monoclonal antibodies
RxNorm normalized name: Monoclonal antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibodies (unconjugated and conjugated)
Trial: 18022544
Drug: Antibody conjugates
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibody conjugates
Trial: 11856086
Drug: ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (8 mg intravenously)
Trial: 10438182
Drug: Rimactane (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimactane (600 mg)
Trial: 10438182
Drug: Generic rifampicin
RxNorm normalized name: rifampicin
DrugBank: Rifampin (DB01045)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generic rifampicin preparations (600 mg)
Trial: 7563559
Drug: 11‐mg/d dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11‐mg/d dose of transdermal nicotine
Trial: 7563559
Drug: 22‐mg/d dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22‐mg/d dose of transdermal nicotine
Trial: 7563559
Drug: 44‐mg/d dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 44‐mg/d dose of transdermal nicotine
Trial: 7563559
Drug: 44‐mg/d dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 44‐mg/d dose of nicotine patch therapy
Trial: 7563559
Drug: Week 2
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Week 2 patch dose
Trial: 27976801
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of all four antibacterial antibodies (anti-CBir1, anti-OmpC, anti-A4-Fla2, anti-Fla-X) at baseline
Trial: 27976801
Drug: Baseline quartile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline quartile sum score for all six antimicrobial antibodies
Trial: 25306557
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg benralizumab
Trial: 25306557
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg benralizumab
Trial: 25306557
Drug: benralizumab (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benralizumab (any dose)
Trial: 22039087
Drug: Preoperative CRT
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative CRT with 5‐fluorouracil (5‐FU) continuous infusion followed by surgery
Trial: 19220764
Drug: New gustatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New gustatory stimulant of salivary secretion containing weaker malic acid, fluoride, and xylitol
Trial: 19220764
Drug: Traditional citric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional citric acid-based gustatory stimulant
Trial: 17241860
Drug: MMX mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMX mesalamine 2.4 g/day
Trial: 17241860
Drug: MMX mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMX mesalamine 4.8 g/day
Trial: 17241860
Drug: ASACOL 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASACOL 2.4 g/day
Trial: 15066738
Drug: Tea tree
RxNorm normalized name: tea tree
DrugBank: Melaleuca alternifolia leaf (DB14372)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea tree oil regimen (10% cream, 5% body wash for 5 days)
Trial: 15066738
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (mupirocin 2% nasal ointment, chlorhexidine gluconate 4% soap, silver sulfadiazine 1% cream for 5 days)
Trial: 15066738
Drug: Mupirocin 2%
RxNorm normalized name: MUPIROCIN 2% OINT
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin 2% nasal ointment
Trial: 15066738
Drug: Tea tree
RxNorm normalized name: tea tree
DrugBank: Melaleuca alternifolia leaf (DB14372)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea tree cream
Trial: 15066738
Drug: Tea tree
RxNorm normalized name: tea tree
DrugBank: Melaleuca alternifolia leaf (DB14372)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea tree treatment
Trial: 1888324
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment (special kind of behaviour therapy)
Trial: 6337951
Drug: Captopril (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (450 mg/day)
Trial: 6337951
Drug: Hydrochlorothiazide (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (up to 100 mg/day)
Trial: 1794215
Drug: Captopril monotherapy
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril monotherapy
Trial: 22129616
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min) with gastric distension at 0 ml (V0)
Trial: 22129616
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min) with gastric distension at 100 ml (V100)
Trial: 22129616
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min) with gastric distension at 300 ml (V300)
Trial: 22129616
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min) with gastric distension at 500 ml (V500)
Trial: 22129616
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min) with gastric distension (all volumes)
Trial: 16805931
Drug: Intraoperative fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraoperative fentanyl with ketoprofen (1.5 mg kg‐1)
Trial: 12505963
Drug: Interscalene group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene group (n = 20) received clonidine 150 micro g in 15 mL of saline through the catheter
Trial: 12505963
Drug: Systemic group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic group (n = 20) received 15 mL of saline through the catheter and clonidine 150 micro g (1 mL) subcutaneously
Trial: 9075128
Drug: felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 5 mg once daily for 4 weeks
Trial: 8371932
Drug: Subcutaneous interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous interferon alpha‐2a (3 million units/m2) every other day for 8 weeks
Trial: 18984557
Drug: Sequential exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential exposure to program sections over 5 weeks
Trial: 12410648
Drug: DDAVP (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDAVP (300 micro g) nasal spray
Trial: 31764363
Drug: Perioperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative intravenous dexamethasone
Trial: 26795265
Drug: Combined dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dietary supplement (2 capsules/day)
Trial: 26795265
Drug: Combined dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dietary supplement (10 or 50 mg/kg orally)
Trial: 26251958
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 500 μg
Trial: 26251958
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 μg
Trial: 24070494
Drug: Salmeterol xinafoate
RxNorm normalized name: Salmeterol Xinafoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol xinafoate (SLM) 50 μg
Trial: 24070494
Drug: Combination FP
RxNorm normalized name: FP-1096
DrugBank: FP-1096 (DB05310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination FP 100 μg + SLM 50 μg
Trial: 24070494
Drug: Salmeterol (SLM)
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Salmeterol (SLM) 10(‐8) mol/L with Fluticasone (FP) 10(‐9) mol/L
Trial: 24070494
Drug: Salmeterol (SLM)
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Salmeterol (SLM) 10(‐9) mol/L with Fluticasone (FP) 10(‐11) mol/L
Trial: 20003200
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin treatment (Group 1; blood glucose concentration 4.4‐6.1 mmol/l)
Trial: 20003200
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin treatment (Group 2; blood glucose level 7.0 mmol/l‐11.0 mmol/l)
Trial: 11564247
Drug: High-dose mannitol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose mannitol (HDM)
Trial: 11564247
Drug: Conventional-dose mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional-dose mannitol
Trial: 2510282
Drug: Rioprostil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rioprostil (600 micrograms, single oral dose)
Trial: 31944277
Drug: Ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingenol mebutate gel 0.05%
Trial: 28449910
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (bi-weekly educational classes)
Trial: 23525434
Drug: Diesel exhaust
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diesel exhaust inhalation
Trial: 9874861
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine 150 micrograms
Trial: 11000660
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral antacid, alugel hydroxide 300 mg)
Trial: 7198209
Drug: Lecithin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lecithin (10 gm three times daily for 3 months)
Trial: 7198209
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 gm three times daily for 3 months)
Trial: 31626213
Drug: Medical non-elastic
RxNorm normalized name: elastin
DrugBank: Elastin (human) (DB15364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical non-elastic hypoallergenic patch (placebo)
Trial: 24943808
Drug: Maternal use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal use of any antibiotics during pregnancy
Trial: 24943808
Drug: Child's use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child's use of antibiotics during the first year of life
Trial: 24943808
Drug: Child's use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child's use of amoxicillin
Trial: 21344494
Drug: Additive tolterodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additive tolterodine extended release (ER) 4 mg q.d.
Trial: 17583187
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (CC) 8 mg once daily, with dosage adjustment to 16 mg if BP was not normalized
Trial: 11243303
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (CC)
Trial: 15612963
Drug: Long-acting beta-agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting beta-agonist (LABA) treatment
Trial: 15612963
Drug: Increased doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased doses of inhaled corticosteroid (ICS)
Trial: 15612963
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months of treatment
Trial: 12377957
Drug: Distant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distant treatment failures
Trial: 8592764
Drug: NANP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NANP vaccine
Trial: 2767067
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (0.300 g.kg‐1 body mass)
Trial: 2767067
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride placebo (0.045 g.kg‐1 body mass)
Trial: 603002
Drug: Alphaxalone/alphadalone (0.036
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alphaxalone/alphadalone (0.036 ml/kg)
Trial: 29027653
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 µg kg⁻¹
Trial: 29027653
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 µg kg⁻¹
Trial: 20214329
Drug: Puerarin preconditioning
RxNorm normalized name: Pueraria montana var. chinensis root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Puerarin preconditioning (0.6 g in 250 mL 5% glucose solution for intravenous dripping every day for one week before operation)
Trial: 29301558
Drug: Perindopril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (ACE inhibitor)
Trial: 15062889
Drug: telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telmisartan (40 to 80 mg once daily)
Trial: 15062889
Drug: valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan (80 to 160 mg once daily)
Trial: 3130687
Drug: Oxamniquine treatment
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxamniquine treatment
Trial: 8005825
Drug: Etanidazole (ETA)
RxNorm normalized name: Tinidazole
DrugBank: Etanidazole (DB12736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etanidazole (ETA) with accelerated fractionation XRT 20 Gy BID to 40 Gy in 2 weeks and continuous infusion during brachytherapy
Trial: 2551469
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 mg by metered dose inhaler twice a day)
Trial: 31303567
Drug: Sertraline (n=1202)
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline (n=1202)
Trial: 31303567
Drug: Fluoxetine (active-control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (active-control group; n=754)
Trial: 30527258
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g Resistant Maltodextrin (RMD)
Trial: 30527258
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g Resistant Maltodextrin (RMD)
Trial: 30527258
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g Resistant Maltodextrin (RMD)
Trial: 22849533
Drug: Aripiprazole (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (average final dose 7.8 mg/day, range 2.5-15 mg/day)
Trial: 20026576
Drug: Therapy focused
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy focused on familiarizing patients with communicative functions of gestures and improving spatial precision of gestures
Trial: 11225511
Drug: Therapy
RxNorm normalized name: Ice Therapy
DrugBank: Levomenthol (DB00825)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Therapy
Trial: 20026576
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ten patients tested repeatedly without interpolated therapy)
Trial: 15876309
Drug: Levocetirizine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocetirizine treatment
Trial: 10098759
Drug: Chemotherapy (alternating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (alternating courses of etoposide‐carboplatin and etoposide‐ifosfamide for a total of four courses) + 40 Gy local irradiation
Trial: 10098759
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (combination of chemotherapy and local radiotherapy)